At the 2025 Alzheimer’s Association International Conference (AAIC), one of the bigger splashes was made by a cardiovascular drug. In a presentation on July 30, ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...
Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service. The need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback